// App-Quantinova.ai

9554 : Off treatment survival (OTS) in patients (pts) with advanced melanoma after anti-PD1 therapy.

Researchers

Presenter

  • Shelly Ann Christiansen

Principal Investigators

  • David Swoboda

  • Kellie Gardner

  • Suthee Rapisuwon

  • Michael B. Atkins

  • Geoffrey Thomas Gibney

Medical Centers

  • Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC

  • Georgetown University, Washington, DC

  • Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC

  • Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC

  • Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

  • Moffitt Cancer Center, Tampa, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved